Redeye endorses ISAB’s new IRS contract worth SEK 1.4m with a new US client within the respiratory pharma sector. We are positive about the increased customer base and the demand for IRS and DissolvIt. We expect to see more orders like this during the rest of 2022 and reiterate our Base Case.

Link to the analysis